中国卫生标准管理
中國衛生標準管理
중국위생표준관리
CHINA HEALTH STANDARD MANAGEMENT
2015年
9期
224-225
,共2页
帕罗西汀%治疗%神经衰弱
帕囉西汀%治療%神經衰弱
파라서정%치료%신경쇠약
Paroxetine%Treatment%Neurasthenia
目的:对帕罗西汀治疗神经衰弱的临床效果进行分析研究。方法选取于2014年2月~2014年12月期间在我院接受治疗的48例神经衰弱患者随机分成对照组和治疗组,每组分别40例患者。对照组患者给予舒眠胶囊治疗,治疗组患者给予帕罗西汀治疗,对两种治疗方法的临床效果进行对比。结果治疗组患者的HAMD、SDS评分均显著低于对照组,睡眠障碍,焦虑、抑郁,情感淡漠,躯体症状等HAMD四个因素评分均显著低于对照组,同时治疗组的治疗总有效率显著高于对照组,差异显著,治疗有统计学意义(P<0.05)。结论对神经衰弱患者采用帕罗西汀治疗具有显著的临床疗效,值得在临床实践中进行广泛应用。
目的:對帕囉西汀治療神經衰弱的臨床效果進行分析研究。方法選取于2014年2月~2014年12月期間在我院接受治療的48例神經衰弱患者隨機分成對照組和治療組,每組分彆40例患者。對照組患者給予舒眠膠囊治療,治療組患者給予帕囉西汀治療,對兩種治療方法的臨床效果進行對比。結果治療組患者的HAMD、SDS評分均顯著低于對照組,睡眠障礙,焦慮、抑鬱,情感淡漠,軀體癥狀等HAMD四箇因素評分均顯著低于對照組,同時治療組的治療總有效率顯著高于對照組,差異顯著,治療有統計學意義(P<0.05)。結論對神經衰弱患者採用帕囉西汀治療具有顯著的臨床療效,值得在臨床實踐中進行廣汎應用。
목적:대파라서정치료신경쇠약적림상효과진행분석연구。방법선취우2014년2월~2014년12월기간재아원접수치료적48례신경쇠약환자수궤분성대조조화치료조,매조분별40례환자。대조조환자급여서면효낭치료,치료조환자급여파라서정치료,대량충치료방법적림상효과진행대비。결과치료조환자적HAMD、SDS평분균현저저우대조조,수면장애,초필、억욱,정감담막,구체증상등HAMD사개인소평분균현저저우대조조,동시치료조적치료총유효솔현저고우대조조,차이현저,치료유통계학의의(P<0.05)。결론대신경쇠약환자채용파라서정치료구유현저적림상료효,치득재림상실천중진행엄범응용。
Objective Clinical effect of paroxetine in treatment of neurasthenia is to be studied. Methods Select 48 neurasthenia patients that are treated in hospital from February 2014 to December 2014 and separate them into control group and study group at random with 40 patients in each group;patients in control group are given good-sleep capsule medication, while patients in study group are given paroxetine medication treatment;and then compare clinical treatment effects between two groups. Results Patients’scores of HAMD and SDS in study group are much lower than those in control group; and what’s more, with regarding to four aspects of HAMD, including sleep disorder, anxiety, emotional indifference, and physical state; scores in study group are lower than counterparts in control group; and patients’treatment efficacy in study group is much higher than that in control group; there is a treatment differential between two groups and such a differential has statistic value(P<0.05). Conclusion Paroxetine medication is of efficacy in treatment of neurasthenia; thus, such a treatment is quite worthwhile to be promoted and applied clinically.